AVD American Vanguard

American Vanguard Enters into Agreement with Adama to Acquire Certain Crop Protection Assets in the U.S.

American Vanguard Corporation (NYSE:AVD), through its principal operating subsidiary, AMVAC Chemical Corporation, today announced the signing of an agreement to acquire certain US assets relating to the three crop protection product lines - Abamectin, Chlorothalonil and Paraquat - from subsidiaries of Adama Agricultural Solutions Ltd., which is part of the China National Chemical Corporation (“ChemChina”) group. Financial terms of the agreement were not disclosed.

The acquisition is part of a consent agreement between the Federal Trade Commission (the “FTC”), on the one hand, and ChemChina and Syngenta AG, on the other hand, under which ChemChina is required to divest these assets as a pre-condition for ChemChina’s proposed acquisition of Syngenta AG. The FTC published the subject consent decree on its website on April 4, 2017, is soliciting public comment for a period of 30 days and will also publish it in the Federal Register imminently.

The assets include trademarks, product registrations, registration data, and commercial information that relate to the marketing and sale of these three products in the crop protection market within the United States.

Eric Wintemute, Chairman & CEO of American Vanguard commented: “We are excited about the prospect of acquiring these product lines for crop use domestically. For some time, we have been reporting that industry consolidation will result in acquisition opportunities, and this is exactly the kind of deal that we had been anticipating. We expect to give more color on this deal once the ChemChina-Syngenta merger closes.”

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® & Russell 3000® Indexes and the Standard & Poors Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

In its public commentary, the Company may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

EN
05/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on American Vanguard

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

American Vanguard Corp: 1 director

A director at American Vanguard Corp bought 12,000 shares at 5.970USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

 PRESS RELEASE

American Vanguard Withdraws Dacthal Registration

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD) today announced that, following its decision in April 2024 to voluntarily stop sales of Dacthal herbicide products, the Company has submitted to the Environmental Protection Agency (“EPA”) voluntary cancellation requests for all of its federal registrations of those products. Those registrations are currently the subject of an emergency suspension order that was issued by EPA on August 6, 2024. In connection with its action, the Company made the following statements. While the Company continues to question E...

 PRESS RELEASE

American Vanguard Reports Q2 2024 Results

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD) today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights – versus Second Quarter 2023: Net sales of $128.2 million v. $132.8 million Adjusted EBITDA1 of $6.2 million v. $10.7 million Earnings per share of $(0.42) v. $(0.04) First Half of 2024 Financial Highlights – versus First Half of 2023: Net sales of $263.4 million v. $257.7 million Adjusted EBITDA of $21.7 million v. $22.2 million Earnings per diluted share of $(0.36) v. $0...

 PRESS RELEASE

American Vanguard Schedules 2024 Second Quarter Earnings Release and C...

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD), today announced that it will report financial results for the second quarter ended June 30, 2024, on Thursday, August 8, 2024, after the close of the stock market. Tim Donelly, Acting CEO, David T. Johnson, VP, CFO and Treasurer, and Mark Bassett, Director will conduct a conference call focusing on operating performance and financial results at 4:30 pm ET / 1:30 pm PT on August 8, 2024. Interested parties may participate in the call by dialing 201-493-6744, please dial in 10 minutes before the scheduled start...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch